Targeting of pyrroline-5-carboxylate reductase (PYCR) reduces drug resistance in multiple myeloma in vitro.

Oudaert, I. (Speaker), Menu, E. (Contributor), De Veirman, K. (Contributor)

Activity: Talk or presentationTalk or presentation at a conference

Period29 Jan 202130 Jan 2021
Held atBelgian Hematological Society, Belgium
Degree of RecognitionNational